| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 9.5% | +16% | $1,427,414,364 | +$222,862,971 | 65,779,464 | +19% | FMR LLC | 31 Dec 2025 |
| MORGAN STANLEY | 8% | +42% | $1,208,606,395 | +$388,661,791 | 55,491,570 | +47% | Morgan Stanley | 31 Dec 2025 |
| Ramaswamy Vivek | 6.8% | -40% | $1,054,779,090 | -$752,013,959 | 48,428,792 | -42% | Ramaswamy Vivek | 31 Dec 2025 |
| QVT Financial LP | 4.3% | -55% | $319,084,556 | -$395,435,884 | 29,381,635 | -55% | QVT Financial LP | 30 Jun 2025 |
| VIKING GLOBAL INVESTORS LP | 3.4% | -32% | $356,989,793 | -$161,027,803 | 23,594,831 | -31% | VIKING GLOBAL INVESTORS LP | 30 Sep 2025 |
| SB INVESTMENT ADVISERS (UK) LTD | 2.3% | -58% | $357,488,273 | -$520,575,193 | 16,413,603 | -59% | SB Investment Advisers (UK) Limited | 31 Dec 2025 |
As of 31 Dec 2025, 394 institutional investors reported holding 508,587,107 shares of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV). This represents 71% of the company’s total 713,634,913 outstanding shares.
The largest institutional shareholders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 9.2% | 65,779,464 | +8.2% | 0.07% | $1,427,414,364 |
| MORGAN STANLEY | 8.2% | 58,359,552 | +32% | 0.08% | $1,266,402,308 |
| VANGUARD GROUP INC | 5.9% | 42,059,041 | +8.4% | 0.01% | $912,681,190 |
| BlackRock, Inc. | 5.8% | 41,170,475 | +3.6% | 0.02% | $893,399,288 |
| QVT Financial LP | 3.7% | 26,387,021 | -10% | 54% | $572,598,356 |
| UBS Group AG | 2.6% | 18,390,792 | +570% | 0.08% | $399,080,188 |
| STATE STREET CORP | 2.4% | 17,361,465 | -7.2% | 0.01% | $376,743,791 |
| SB INVESTMENT ADVISERS (UK) LTD | 2.3% | 16,413,603 | -59% | 3.6% | $356,175,185 |
| GOLDMAN SACHS GROUP INC | 1.5% | 10,982,633 | +365% | 0.03% | $238,323,136 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.5% | 10,677,894 | +48% | 0.35% | $231,710,300 |
| Two Seas Capital LP | 1.4% | 9,791,891 | -17% | 12% | $212,484,035 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 9,247,468 | -0.66% | 0.04% | $200,666,214 |
| Rubric Capital Management LP | 1.3% | 9,000,000 | -55% | 2.3% | $195,300,000 |
| Patient Square Capital LP | 1.1% | 8,166,047 | -35% | 38% | $177,203,220 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 8,153,546 | -0.6% | 0.01% | $176,972,083 |
| PERCEPTIVE ADVISORS LLC | 1.1% | 7,985,461 | +8.4% | 3.2% | $173,284,504 |
| Assenagon Asset Management S.A. | 0.97% | 6,937,112 | +11508% | 0.23% | $150,535,330 |
| VIKING GLOBAL INVESTORS LP | 0.9% | 6,443,191 | -73% | 0.37% | $139,817,245 |
| BAKER BROS. ADVISORS LP | 0.78% | 5,555,017 | +47% | 0.71% | $120,543,869 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.75% | 5,335,125 | +83% | 0.01% | $115,773,000 |
| NORGES BANK | 0.73% | 5,195,859 | 0.01% | $112,750,140 | |
| Jefferies Financial Group Inc. | 0.49% | 3,514,833 | 0.62% | $76,271,877 | |
| MARSHALL WACE, LLP | 0.48% | 3,458,926 | -13% | 0.07% | $75,058,694 |
| ADAR1 Capital Management, LLC | 0.48% | 3,428,962 | +2.4% | 5.6% | $74,408,475 |
| NORTHERN TRUST CORP | 0.46% | 3,285,928 | +0.09% | 0.01% | $71,304,638 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 508,587,107 | $11,032,890,046 | +$193,924,197 | $21.70 | 394 |
| 2025 Q3 | 501,599,656 | $7,589,044,056 | -$160,221,312 | $15.13 | 336 |
| 2025 Q2 | 514,772,354 | $5,801,411,223 | -$418,510,172 | $11.27 | 337 |
| 2025 Q1 | 553,328,719 | $5,583,781,669 | -$111,475,682 | $10.09 | 310 |
| 2024 Q4 | 562,446,665 | $6,653,171,538 | -$86,396,710 | $11.83 | 312 |
| 2024 Q3 | 569,136,749 | $6,567,461,922 | +$223,573,966 | $11.54 | 291 |
| 2024 Q2 | 546,001,457 | $5,771,073,920 | +$151,629,366 | $10.57 | 293 |
| 2024 Q1 | 531,561,894 | $5,603,149,203 | -$165,817,358 | $10.54 | 258 |
| 2023 Q4 | 541,631,584 | $6,081,436,620 | -$171,734,221 | $11.23 | 223 |
| 2023 Q3 | 545,872,779 | $6,375,349,918 | +$537,705,852 | $11.68 | 205 |
| 2023 Q2 | 497,346,775 | $5,012,967,398 | +$397,737,203 | $10.08 | 178 |
| 2023 Q1 | 459,356,125 | $3,389,932,964 | +$349,480,110 | $7.38 | 144 |
| 2022 Q4 | 411,727,361 | $3,289,525,255 | +$291,883,961 | $7.99 | 107 |
| 2022 Q3 | 370,512,297 | $1,192,938,093 | +$30,768,202 | $3.22 | 75 |
| 2022 Q2 | 360,483,554 | $1,467,028,314 | +$45,607,814 | $4.07 | 71 |
| 2022 Q1 | 349,161,599 | $1,724,680,470 | +$48,168,384 | $4.94 | 50 |
| 2021 Q4 | 339,213,133 | $3,416,732,000 | +$3,374,253,000 | $10.08 | 40 |